|
|
 |
|
Viewing report
|
|
|
|
Pulmonary Inhalers & Systemic Drug Delivery: Devices, Drugs, Therapeutics, Market Factors & Forecasts
Greystone Associates, May 2010
Advances in drug formulation and inhalation device design are creating new opportunities for inhaled drug delivery as an alternative to oral and parenteral delivery methods. Much of the interest in pulmonary delivery of systemic drug therapies is focused on chronic diseases and refractory conditions – aliments that require frequent drug administration for a protracted period of time. The role of device design and development in defining and driving emerging opportunities in this sector cannot be overstated. Nebulizers, metered dose inhalers (MDIs), and dry powder inhalers (DPIs) have each found a niche in the quest for optimal treatment and convenient use. While nebulizers have evolved relatively independently of the drug formulations they deliver, the current generation of MDIs and DPIs have been developed or tailored for the specific pharmaceutical being delivered, resulting in improved performance. Several of the emerging drug products covered in this report will have a significant impact in the therapeutic markets they target, improving patient compliance and effectively changing the way important illnesses and conditions are treated.
Feature Summary
- Analyzes commercial products and development-stage candidates within the inhaled systemic drug delivery segment for fifteen major therapeutic markets
- Examines inhaler design factors and combination drug-device product technology issues
- Provides detailed assessments of targeted disease segments, growth rates and market potential
- Examines therapeutic opportunities and risk factors
- Forecasts the impact of new and emerging inhaled systemic drug therapeutics on healthcare markets and prescribing decisions
- Profiles Inhaled systemic drug product market participants, their technology, product development activity, and business strategies
- Provides market data by segment and forecasts demand to 2013
- Evaluates the impact of economic, technology, and regulatory factors on inhaled drug companies and their alliance partners
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Delivering Drugs by Inhalation
Pediatric Drug Delivery
Inhaled CNS Therapeutics - Markets & Opportunities
The Global Drug Delivery Market - Research Trends and Market Outlook
Drug Delivery Device Market to 2017 - Metered Dose Inhalers and Infusion Pumps to be Key Revenue Generators
Nitric Oxide - Therapeutics, Markets and Companies
Drug Cartridge-based Syringes and Injectors: Devices, Therapeutics, Players, Markets and Prospects
Point-of-Use Drug Reconstitution Systems
Global Respiratory Care Devices Market (2010 - 2015)
Point-of-Delivery Drug Reconstitution Systems
|
|
|
|
